The Sapien M3 transcatheter mitral valve replacement system won FDA approval -- making it the first on the market to utilize a transseptal approach -- for the treatment of symptomatic ...

Patients undergoing transcatheter mitral valve replacement (TMVR) who receive direct oral anticoagulants (DOACs) have fewer bleeding and thrombotic events and shorter hospital stays than those taking ...

DENVER, CO—It’s early days, and the studies are small, but two new reports highlight the feasibility of transcatheter mitral valve replacement (TMVR) in patients with severe symptomatic mitral ...

Please provide your email address to receive an email when new articles are posted on . Employing intravascular lithotripsy facilitated transcatheter mitral valve replacement in a patient with severe ...

SAN FRANCISCO -- For selected patients with mitral regurgitation (MR), the Sapien M3 device delivered highly promising 1-year outcomes for the desperate field of transcatheter mitral valve replacement ...

A “minimalist” approach to transfemoral valve-in-valve transcatheter mitral valve replacement (TMVR), not unlike the approach commonly used with TAVI, appears to be safe and feasible when compared ...

IRVINE, Calif. — ReValve Solutions Inc. (ReValve), which has developed a next generation technology for Transcatheter Mitral Valve Replacement (TMVR), announced that an 81-year-old male, with a ...

Hyderabad: The cardiology department of Nizam’s Institute of Medical Sciences (Nims) has achieved a remarkable feat by successfully performing a rare and complex medical procedure called the ...

Paris, January 26, 2026 - HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the ...

European Next-Generation Intervention Cardiolog Market · GlobeNewswire Inc. Dublin, Oct. 13, 2025 (GLOBE NEWSWIRE) -- The "Europe Next-Generation Intervention Cardiology Market: Focus on Product Type, ...